JBT Marel (JBTM) Earnings Date & Reports

Key Takeaways

• Third quarter 2026 revenue of $994 million declined 1% year over year and came in below the consensus estimate of roughly $1.03 billion, pressured by softer consumer packaged goods (CPG) volume.
• Adjusted earnings per share (EPS) of $2.19 beat the $2.10 consensus and rose 13% from $1.94 a year earlier.
• Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) reached a record $179 million, up 5%, with a record 18.0% margin.
• Net income under GAAP (Generally Accepted Accounting Principles) rose 6% to $70 million, with GAAP diluted EPS of $1.34 versus $1.26 in the prior-year quarter.
• Management lowered full-year revenue guidance to $3.95 billion–$4.0 billion but raised its adjusted EBITDA margin and adjusted EPS outlooks.
• The board increased its share repurchase authorization by $500 million to $700 million and bought back roughly 800,000 shares for $94 million during the quarter.
• For additional context, explore JBT Marel's Major News, Today's Price Move, Price Targets, and Forecast pages.
• Explore Trending AI Robots for automated, AI-driven trading ideas.

Earnings Context and Why It Matters

JBT Marel Corporation, formed from the January 2025 combination of JBT and Marel, supplies food and beverage processing technology. Its quarterly results offer a window into capital spending by poultry, meat, seafood, and packaged food producers. The third quarter highlighted a core tension: the company is executing well on margins and cost synergies even as demand in its consumer packaged goods (CPG) end markets stays soft. For investors, the report matters because it tests whether merger-driven efficiency gains can offset uneven revenue growth and support the raised profitability targets management has emphasized since the deal closed.

Reported Results

JBT Marel reported third quarter 2026 revenue of $994 million, down 1% from $1,001 million in the prior-year period and below the roughly $1.03 billion consensus. The shortfall stemmed mainly from lower book-and-ship volume in the Diversified Food and Health business, which serves consumer packaged goods customers.

Profitability came in stronger than the top line. Adjusted EPS reached $2.19, ahead of the $2.10 consensus and up 13% from $1.94 a year earlier. Adjusted EBITDA rose 5% to a record $179 million, equating to a record 18.0% margin. GAAP net income increased 6% to $70 million, a 7.0% net income margin, while GAAP diluted EPS was $1.34 compared with $1.26.

By segment, Protein Solutions revenue grew 6% to $469 million on poultry volume, with a 22.4% adjusted EBITDA margin. Prepared Food and Beverage Solutions revenue declined 6% to $525 million, though its margin improved to 19.2%. Quarter-end backlog stood at $1.52 billion, and inbound orders totaled $976 million. Year-to-date free cash flow was $252 million, up about $90 million year over year.

Management revised full-year 2026 revenue guidance to $3.95 billion–$4.0 billion, implying roughly 5% growth at the midpoint including a 1.5% foreign exchange benefit. It simultaneously raised the adjusted EBITDA margin outlook to 17.25%–17.5% and adjusted EPS guidance to $8.10–$8.40, with GAAP diluted EPS expected at $4.30–$4.60.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market using technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs with customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is designed to surface trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. For investors tracking names like JBT Marel, it offers a structured way to identify comparable setups and monitor shifting market conditions.

Market Reaction and Investor Sentiment

The earnings release drew a divided response from investors. The adjusted EPS beat, record margins, and raised profitability guidance signaled strong operational execution, while the revenue miss and lowered full-year sales outlook reflected persistent softness in consumer packaged goods demand. This mix left sentiment focused on whether margin gains from cost synergies, pricing, and footprint optimization can keep compensating for slower revenue growth. The expanded $700 million buyback authorization and healthy free cash flow were seen as supportive signals, but investors weighed those positives against the trimmed top-line forecast and continued uncertainty in CPG-related end markets.

Forward Outlook and Key Factors to Monitor

Looking ahead, investors should watch how JBT Marel's demand environment evolves across its two segments. Management expects a seasonally stronger fourth quarter, helped by a robust poultry backlog and typical year-end food facility activity. Protein Solutions is positioned for continued growth, while the Prepared Food and Beverage Solutions segment faces ongoing headwinds from the Diversified Food and Health business.

Several factors will shape the next several quarters. Cost synergy realization, including labor productivity, supply chain savings, and facility consolidation, remains central to the company's margin trajectory. Management indicated further footprint closures are planned through 2027, which should extend efficiency gains but require careful execution.

Other items to monitor include CPG capital spending trends, tariff and inflationary pressures, and free cash flow conversion. The company's ability to balance share repurchases against a net leverage ratio of roughly 2.0 to 2.5 times will also be an important signal of financial flexibility. Backlog conversion and inbound order trends will offer early evidence of whether revenue growth can reaccelerate toward management's mid-single-digit ambition.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations